OSRX Survey Results are In: Patient Satisfaction Ranges from 89-99% for Compounded Medications
The results of our 2024 Patient Satisfaction Survey are in! More than 2,800 patients from ophthalmic practices around the country were asked about their satisfaction with OSRX® prescription eye drops, which combine multiple medications into a single bottle. Highlights from the findings include:
- 98% say taking fewer drops helps them comply with their daily dosing regimen (4% increase over 2023)
- 98% say they are satisfied or very satisfied with OSRX overall (4% increase over 2023)
- 98% say their shipment arrived within the expected timeframe (5% increase over 2023)
- 90% agree their OSRX medication was reasonably priced (3% increase over 2023)
- 99% agree their call was answered or returned in a timely manner (1% increase over 2023)
- 89% agree they prefer the convenience of having their medication shipped to their home
- 99% agree all their questions were answered and resolved, among those who called (2% increase over 2023)
- 96% would recommend OSRX to a friend or colleague (2% increase over 2023)
OSRX works directly with ophthalmic physicians to provide quality compounded medications tailored to meet patient needs for post-op care, combination therapy, and low-dose atropine. By combining multiple medications into a single bottle, the medications are affordable, promote dosing adherence and save time for patients. Medications are prescribed by doctors and can be shipped to the practice or directly to patient homes.
Chief Commercial Officer Eric Garner adds, “The positive survey feedback underscores the impact of our patient-driven business model that empowers physicians to deliver quality medications and unrivaled customer service. Our focus on simplifying dosing regimens is not only promoting patient compliance but also reducing out-of-pocket costs by sparing patients from having to purchase multiple medications — making quality eye care more accessible.“
Interested in exploring compounded medications for your practice?
Connect with An Account Executive to Learn More